Michael A.  Beindorff net worth and biography

Michael Beindorff Biography and Net Worth

Director of LifeVantage
Mr. Beindorff has been a member of our board of directors since January 2012. Mr. Beindorff brings more than thirty years of experience in general management, operations, sales and marketing with a strong track record of building and leading disciplined organizational teams, driving rapid, profitable growth and delivering results across a variety of business environments. He currently serves as Principal & President of the Far Niente Group, a management consultancy focused on helping clients build effective business models, strong differentiated brands, viable product lines and sustainable businesses while maximizing return on investment, a position he has held since 2008. From 2004 to 2008, he served as Chief Operating Officer of Exclusive Resorts, a world's leading private club for luxury travel experiences, where he helped build a world class leadership team and a profitable, sustainable business. From 2002 to 2004, he served as Principal & President of the Greentree Group, a management consultancy helping clients build strong brands and effective business models. From 1999 to 2002, he served first as President & COO and then as Chairman & Chief Executive Officer of PlanetRx.com, an internet pharmacy and on-line health portal. From 1995 to 1999, he served as Executive Vice President of Marketing, Operations & Product Management for VISA. From 1978 to 1995, he held various positions leading global advertising, sales, marketing and brand management for The Coca-Cola Company and Rhodes Furniture. Mr. Beindorff received his Bachelor of Science in Business Administration from the University of Alabama and his Masters of Business Administration from the Gouzuietta Business School at Emory University.

What is Michael A. Beindorff's net worth?

The estimated net worth of Michael A. Beindorff is at least $933,209.94 as of November 20th, 2023. Mr. Beindorff owns 54,798 shares of LifeVantage stock worth more than $933,210 as of March 15th. This net worth approximation does not reflect any other investments that Mr. Beindorff may own. Learn More about Michael A. Beindorff's net worth.

How do I contact Michael A. Beindorff?

The corporate mailing address for Mr. Beindorff and other LifeVantage executives is 9785 S. MONROE STREET SUITE 400, SANDY UT, 84070. LifeVantage can also be reached via phone at (801) 432-9000 and via email at scott.vanwinkle@icrinc.com. Learn More on Michael A. Beindorff's contact information.

Has Michael A. Beindorff been buying or selling shares of LifeVantage?

Michael A. Beindorff has not been actively trading shares of LifeVantage in the last ninety days. Most recently, Michael A. Beindorff sold 5,500 shares of the business's stock in a transaction on Monday, November 20th. The shares were sold at an average price of $6.00, for a transaction totalling $33,000.00. Following the completion of the sale, the director now directly owns 54,798 shares of the company's stock, valued at $328,788. Learn More on Michael A. Beindorff's trading history.

Are insiders buying or selling shares of LifeVantage?

In the last year, LifeVantage insiders bought shares 4 times. They purchased a total of 1,889 shares worth more than $14,816.63. In the last year, insiders at the sold shares 1 times. They sold a total of 8,000 shares worth more than $161,200.00. The most recent insider tranaction occured on February, 10th when Director Raymond B Greer sold 8,000 shares worth more than $161,200.00. Insiders at LifeVantage own 20.7% of the company. Learn More about insider trades at LifeVantage.

Information on this page was last updated on 2/10/2025.

Michael A. Beindorff Insider Trading History at LifeVantage

See Full Table

Michael A. Beindorff Buying and Selling Activity at LifeVantage

This chart shows Michael A Beindorff's buying and selling at LifeVantage by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$20k$0$20kTotal Insider BuyingTotal Insider Selling

LifeVantage Company Overview

LifeVantage logo
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.
Read More

Today's Range

Now: $17.03
Low: $16.50
High: $17.38

50 Day Range

MA: $19.80
Low: $15.40
High: $25.62

2 Week Range

Now: $17.03
Low: $5.22
High: $27.38

Volume

160,640 shs

Average Volume

272,903 shs

Market Capitalization

$213.74 million

P/E Ratio

30.41

Dividend Yield

1.02%

Beta

0.74